A recent clinical study published in The Journal of Clinical Psychiatry found that a single psilocybin dose combined with psychological support significantly reduces chronic suicidal thoughts in people with severe, treatment-resistant depression — with relief lasting months. This matters because standard antidepressants fail for roughly 30% of patients with major depression, and psychedelic-assisted therapy is emerging as a promising new approach to help people who haven't responded to existing treatments. While this study was conducted in real-world settings rather than just controlled labs, it's worth noting that the broader evidence base for psychedelic-assisted therapies is still developing. Multiple studies in treatment-resistant depression, PTSD, and other conditions suggest these approaches can produce meaningful benefits, but more research is needed before we can say definitively how well they'll work across different patient populations and settings.